Sign In
Buy COLL
$31.06
+0.580 (+1.90%)
At Close: Jun 03, 2026
Short Interest in Collegium Pharmaceutical Inc (NASDAQ:COLL) Expands By 8.4%
06:38am, Wednesday, 01'st Apr 2020
Collegium Pharmaceutical Inc (NASDAQ:COLL) saw a large increase in short interest in March. As of March 13th, there was short interest totalling 5,582,500 shares, an increase of 8.4% from the February
Collegium: Unjustified Sell-Off Alters My Plans
01:21pm, Monday, 30'th Mar 2020
Collegium Pharmaceutical recently reported impressive Q4/2019 earnings with a beat on EPS and revenue. Xtampza ER continues to impress and is steadily moving cl
Collegium Pharmaceutical Inc (NASDAQ:COLL) Expected to Announce Quarterly Sales of $78.31 Million
08:54am, Sunday, 29'th Mar 2020
Wall Street analysts predict that Collegium Pharmaceutical Inc (NASDAQ:COLL) will report sales of $78.31 million for the current fiscal quarter, Zacks reports. Six analysts have made estimates for Col
Albireo Pharma (ALBO) Received its Third Buy in a Row
02:26pm, Friday, 27'th Mar 2020
After Wedbush and Needham gave Albireo Pharma (NASDAQ: ALBO) a Buy rating last month, the company received another Buy, this time from William Blair.
Albireo Pharma (ALBO) Received its Third Buy in a Row
02:26pm, Friday, 27'th Mar 2020
After Wedbush and Needham gave Albireo Pharma (NASDAQ: ALBO) a Buy rating last month, the company received another Buy, this
William Blair Remains a Buy on Revance Therapeutics (RVNC)
02:26pm, Friday, 27'th Mar 2020
In a report released today, Tim Lugo from William Blair maintained a Buy rating on Revance Therapeutics (RVNC). The company's shares closed last Monday at
William Blair Remains a Buy on Revance Therapeutics (RVNC)
02:26pm, Friday, 27'th Mar 2020
In a report released today,
Tim Lugo
from William Blair maintained a
Buy
rating on Revance Therapeutics (
RVNC
–
Research Report
). The company’s shares closed last Monday at $15.27.
According to
William Blair Maintains a Buy Rating on Biohaven Pharmaceutical Holding Co (BHVN)
02:26pm, Friday, 27'th Mar 2020
William Blair analyst Tim Lugo maintained a Buy rating on Biohaven Pharmaceutical Holding Co (BHVN) on March 23. The company's shares closed last Monday
William Blair Maintains a Buy Rating on Biohaven Pharmaceutical Holding Co (BHVN)
02:26pm, Friday, 27'th Mar 2020
William Blair analyst Tim Lugo maintained a Buy rating on Biohaven Pharmaceutical Holding Co (BHVN – Research Report) on March
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
11:34am, Friday, 27'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL), with a price target of $38.00. The
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
11:34am, Friday, 27'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report),
Analysts Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) Will Announce Earnings of $0.35 Per Share
07:32am, Friday, 27'th Mar 2020
Wall Street analysts expect Collegium Pharmaceutical Inc (NASDAQ:COLL) to announce $0.35 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts h
The Call On Collegium Pharmaceuticals
04:36pm, Thursday, 26'th Mar 2020
Today, we take an in-depth look at a 'Tier 3' biopharma concern named Collegium Pharmaceuticals. The shares were lifted over the past few months by increasingly
COLL or NBIX: Which Is the Better Value Stock Right Now?
03:40pm, Thursday, 26'th Mar 2020
COLL vs. NBIX: Which Stock Is the Better Value Option?
COLL or NBIX: Which Is the Better Value Stock Right Now?
03:40pm, Thursday, 26'th Mar 2020
COLL vs. NBIX: Which Stock Is the Better Value Option?
